Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

Reid, David M, Prof ; Devogelaer, Jean-Pierre, Prof ; Saag, Kenneth, Prof ; Roux, Christian, Prof ; Lau, Chak-Sing, Prof ; Reginster, Jean-Yves, Prof ; Papanastasiou, Philemon, PhD ; Ferreira, Alberto, PhD ; Hartl, Florian, MD ; Fashola, Taiwo, PhD ; Mesenbrink, Peter, PhD ; Sambrook, Philip N, Prof

The Lancet (British edition), 2009-04, Vol.373 (9671), p.1253-1263 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível